Fig. 4. Isoflurane concentrations (mean ± SD) required to produce immobility in response to noxious stimulation increase with decreasing interstimulus interval. MK801  (an N -methyl-d-aspartate antagonist that impairs temporal summation) administration added to isoflurane administration prevents shorter interstimulus intervals from provoking movement at greater isoflurane concentrations.